Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
256.35
+0.53 (0.21%)
At close: Jul 31, 2026, 4:00 PM EDT
257.00
+0.65 (0.25%)
After-hours: Jul 31, 2026, 5:16 PM EDT

Johnson & Johnson Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
21,03726,80414,06635,15317,94120,878
Depreciation & Amortization
7,7517,5037,3397,4866,9707,390
Stock-Based Compensation
1,4141,3541,1761,1621,1381,135
Other Adjustments
-1,6141,587-152-23,517-844-1,755
Change in Receivables
-1,445-1,781-406-624-1,290-2,402
Changes in Inventories
-1,796-1,450-1,128-1,323-2,527-1,248
Changes in Accounts Payable
2,3072,3771,6212,3461,0982,437
Changes in Other Operating Activities
-46-11,8641,7502,108-1,292-3,025
Operating Cash Flow
27,60824,53024,26622,79121,19423,410
Operating Cash Flow Growth
19.89%1.09%6.47%7.54%-9.47%-0.53%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-5,364-4,832-4,424-4,543-4,009-3,652
Purchases of Intangible Assets
-16-385-1,783-470--
Purchases of Investments
-788-920-1,726-10,906-32,384-30,394
Proceeds from Sale of Investments
1,0761,6612,46219,39041,60925,006
Cash Acquisitions
-3,083-17,541-15,146--17,652-60
Proceeds from Business Divestments
480720675358543711
Other Investing Activities
781-2,2911,343-2,951-478-294
Investing Cash Flow
-7,177-23,588-18,599878-12,371-8,683

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
18,38314,58615,27713,74316,1341,997
Short-Term Debt Repaid
-16,949-12,330-9,463-22,973-6,550-1,190
Net Short-Term Debt Issued (Repaid)
1,4342,2565,814-9,2309,584807
Long-Term Debt Issued
-9,1386,660-25
Long-Term Debt Repaid
-3,006-1,757-1,453-1,551-2,134-1,802
Net Long-Term Debt Issued (Repaid)
-3,0067,3815,207-1,551-2,132-1,797
Issuance of Common Stock
4,3923,4188381,0941,3291,036
Repurchase of Common Stock
-8,075-5,953-2,432-5,054-6,035-3,456
Net Common Stock Issued (Repurchased)
-3,683-2,535-1,594-3,960-4,706-2,420
Common Dividends Paid
-12,621-12,381-11,823-11,770-11,682-11,032
Other Financing Activities
-667-260-73610,68665395
Financing Cash Flow
-18,543-5,539-3,132-15,825-8,871-14,047

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-43201-289-112-312-178
Net Cash Flow
1,845-4,3962,2467,732-360502

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
22,24419,69819,84218,24817,18519,758
Free Cash Flow Growth
19.92%-0.73%8.73%6.19%-13.02%-2.14%
FCF Margin
22.71%20.91%22.34%21.43%21.48%25.09%
Free Cash Flow Per Share
9.128.118.247.136.457.39
Levered Free Cash Flow
22,31728,17530,24530,44625,63321,790
Unlevered Free Cash Flow
24,67612,72522,89225,26917,34720,506
SEC Filings: 10-K · 10-Q